Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?

Area of Science:

• Neurology
• Clinical Neuroscience

Background:

• Chronic inflammatory demyelinating polyradiculopathy (CIDP) is a rare neurological disorder.
• Clinical presentation and outcomes can differ significantly between primary and secondary forms of CIDP.

Purpose of the Study:

• To compare the clinical and electrodiagnostic characteristics of primary and secondary CIDP.
• To elucidate differences in disease course and prognosis between primary and secondary CIDP.

Main Methods:

• Retrospective analysis of 65 CIDP patients diagnosed using European Federation of Neurological Societies/Peripheral Nerve Society criteria.
• Detailed clinical assessment, neurophysiological studies (motor/sensory nerve conduction, F-waves), and etiological investigations.
• Categorization into primary CIDP and secondary CIDP based on underlying conditions; treatment included prednisolone, azathioprine, and specific therapies for secondary causes.

Main Results:

• Twenty-five patients (38.5%) had secondary CIDP, most commonly associated with diabetes mellitus, POEMS syndrome, and monoclonal gammopathies.
• Secondary CIDP patients were older, exhibited less frequent relapsing-remitting courses, and showed more frequent dysautonomia compared to primary CIDP.
• Demyelinating features were more pronounced in primary CIDP, which also demonstrated a better treatment outcome.

Conclusions:

• Secondary CIDP constitutes a significant proportion of all CIDP cases.
• Secondary CIDP is characterized by a progressive disease course, less pronounced demyelination, and a poorer prognosis compared to primary CIDP.
• Distinguishing between primary and secondary CIDP is essential for tailoring treatment and predicting patient outcomes.